阿尔茨海默氏-话题@MedSci

#阿尔茨海默氏#

127篇内容 | 2917人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1990429, encodeId=4b2119904297c, content=<a href='/topic/show?id=b8eb9e78216' target=_blank style='color:#2F92EE;'>#阿尔茨海默氏#</a>, objectTitle=Theranexus宣布1b期研究结果，证明与多奈哌齐相比，其阿尔茨海默氏病候选药物THN201的药理学特性得到了扩展, objectType=article, longId=186520, objectId=88ea186520c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88ea186520c4, replyNumber=0, likeNumber=84, createdTime=2020-07-29, rootId=0, userName=zhs3882, userId=b952312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88ea186520c4, moduleTitle=Theranexus宣布1b期研究结果，证明与多奈哌齐相比，其阿尔茨海默氏病候选药物THN201的药理学特性得到了扩展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88ea186520c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990423, encodeId=67b81990423f6, content=<a href='/topic/show?id=b8eb9e78216' target=_blank style='color:#2F92EE;'>#阿尔茨海默氏#</a>, objectTitle=Biogen的aducanumab治疗阿尔茨海默氏病符合III期试验终点, objectType=article, longId=181870, objectId=66f71818e0a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66f71818e0a7, replyNumber=0, likeNumber=75, createdTime=2020-09-19, rootId=0, userName=zhs3882, userId=b952312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66f71818e0a7, moduleTitle=Biogen的aducanumab治疗阿尔茨海默氏病符合III期试验终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66f71818e0a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990425, encodeId=bf3d19904255b, content=<a href='/topic/show?id=b8eb9e78216' target=_blank style='color:#2F92EE;'>#阿尔茨海默氏#</a>, objectTitle=初步调查排除了中国阿尔茨海默氏症药物开发者的学术造假行为, objectType=article, longId=184027, objectId=968518402e4c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=968518402e4c, replyNumber=0, likeNumber=58, createdTime=2020-01-16, rootId=0, userName=zhs3882, userId=b952312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=968518402e4c, moduleTitle=初步调查排除了中国阿尔茨海默氏症药物开发者的学术造假行为, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=968518402e4c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990435, encodeId=76741990435fe, content=<a href='/topic/show?id=b8eb9e78216' target=_blank style='color:#2F92EE;'>#阿尔茨海默氏#</a>, objectTitle=Eur Respir J：轻度至中度阿尔茨海默氏病患者阻塞性睡眠呼吸暂停和认知功能下降, objectType=article, longId=196230, objectId=f4891962300b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4891962300b, replyNumber=0, likeNumber=69, createdTime=2020-09-21, rootId=0, userName=zhs3882, userId=b952312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4891962300b, moduleTitle=Eur Respir J：轻度至中度阿尔茨海默氏病患者阻塞性睡眠呼吸暂停和认知功能下降, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4891962300b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990431, encodeId=d60f1990431c3, content=<a href='/topic/show?id=b8eb9e78216' target=_blank style='color:#2F92EE;'>#阿尔茨海默氏#</a>, objectTitle=罗氏宣布其阿尔茨海默氏症单抗gantenerumab临床实验失败, objectType=article, longId=187845, objectId=85b418e84596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85b418e84596, replyNumber=0, likeNumber=73, createdTime=2020-07-25, rootId=0, userName=zhs3882, userId=b952312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85b418e84596, moduleTitle=罗氏宣布其阿尔茨海默氏症单抗gantenerumab临床实验失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85b418e84596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990427, encodeId=7e03199042ead, content=<a href='/topic/show?id=b8eb9e78216' target=_blank style='color:#2F92EE;'>#阿尔茨海默氏#</a>, objectTitle=CLIN CHEM LAB MED：脑脊液液体活检确认神经元五种毒素受体（NPTXR）作为阿尔茨海默氏病进展的生物标志物？, objectType=article, longId=185596, objectId=b3ea18559605, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3ea18559605, replyNumber=0, likeNumber=81, createdTime=2020-09-12, rootId=0, userName=zhs3882, userId=b952312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3ea18559605, moduleTitle=CLIN CHEM LAB MED：脑脊液液体活检确认神经元五种毒素受体（NPTXR）作为阿尔茨海默氏病进展的生物标志物？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3ea18559605)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990424, encodeId=255f199042489, content=<a href='/topic/show?id=b8eb9e78216' target=_blank style='color:#2F92EE;'>#阿尔茨海默氏#</a>, objectTitle=JCEM：二甲双胍与糖尿病患者阿尔茨海默氏病风险的关系, objectType=article, longId=183797, objectId=6d97183e978e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d97183e978e, replyNumber=0, likeNumber=66, createdTime=2020-07-19, rootId=0, userName=zhs3882, userId=b952312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d97183e978e, moduleTitle=JCEM：二甲双胍与糖尿病患者阿尔茨海默氏病风险的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d97183e978e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990430, encodeId=714e199043005, content=<a href='/topic/show?id=b8eb9e78216' target=_blank style='color:#2F92EE;'>#阿尔茨海默氏#</a>, objectTitle=默克向FDA申请，将Belsomra用于治疗阿尔茨海默氏症患者的睡眠障碍, objectType=article, longId=187479, objectId=318b18e47983, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=318b18e47983, replyNumber=0, likeNumber=75, createdTime=2020-09-20, rootId=0, userName=zhs3882, userId=b952312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=318b18e47983, moduleTitle=默克向FDA申请，将Belsomra用于治疗阿尔茨海默氏症患者的睡眠障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=318b18e47983)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990422, encodeId=0f7f199042249, content=<a href='/topic/show?id=b8eb9e78216' target=_blank style='color:#2F92EE;'>#阿尔茨海默氏#</a>, objectTitle=又一个阿尔茨海默氏症的候选药宣布失败：安进、诺华放弃BACE抑制剂试验, objectType=article, longId=175370, objectId=81a41e537040, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81a41e537040, replyNumber=0, likeNumber=75, createdTime=2019-11-18, rootId=0, userName=zhs3882, userId=b952312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81a41e537040, moduleTitle=又一个阿尔茨海默氏症的候选药宣布失败：安进、诺华放弃BACE抑制剂试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81a41e537040)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990428, encodeId=be34199042836, content=<a href='/topic/show?id=b8eb9e78216' target=_blank style='color:#2F92EE;'>#阿尔茨海默氏#</a>, objectTitle=INmune Bio宣布临床前数据，证明其sTNF抑制剂降低肥胖者患阿尔茨海默氏病的潜力, objectType=article, longId=185656, objectId=25ab1856567d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25ab1856567d, replyNumber=0, likeNumber=86, createdTime=2020-07-07, rootId=0, userName=zhs3882, userId=b952312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25ab1856567d, moduleTitle=INmune Bio宣布临床前数据，证明其sTNF抑制剂降低肥胖者患阿尔茨海默氏病的潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25ab1856567d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990426, encodeId=2ed11990426d2, content=<a href='/topic/show?id=b8eb9e78216' target=_blank style='color:#2F92EE;'>#阿尔茨海默氏#</a>, objectTitle=Biogen以4500万美元收购Ionis早期阿尔茨海默氏症药物--靶向tau蛋白, objectType=article, longId=185043, objectId=660818504339, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=660818504339, replyNumber=0, likeNumber=81, createdTime=2020-06-02, rootId=0, userName=zhs3882, userId=b952312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=660818504339, moduleTitle=Biogen以4500万美元收购Ionis早期阿尔茨海默氏症药物--靶向tau蛋白, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=660818504339)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990416, encodeId=029a1990416bd, content=<a href='/topic/show?id=b8eb9e78216' target=_blank style='color:#2F92EE;'>#阿尔茨海默氏#</a>, objectTitle=阿尔茨海默氏症的疫苗越来越近了, objectType=article, longId=155254, objectId=942d15525479, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=942d15525479, replyNumber=0, likeNumber=101, createdTime=2019-01-28, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=942d15525479, moduleTitle=阿尔茨海默氏症的疫苗越来越近了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=942d15525479)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990421, encodeId=7c3e1990421ef, content=<a href='/topic/show?id=b8eb9e78216' target=_blank style='color:#2F92EE;'>#阿尔茨海默氏#</a>, objectTitle=AmyPore治疗阿尔茨海默氏症和帕金森症的多肽药物，喜获欧盟资助, objectType=article, longId=167516, objectId=06c616e5160f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06c616e5160f, replyNumber=0, likeNumber=58, createdTime=2020-04-09, rootId=0, userName=zhs3882, userId=b952312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06c616e5160f, moduleTitle=AmyPore治疗阿尔茨海默氏症和帕金森症的多肽药物，喜获欧盟资助, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06c616e5160f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990420, encodeId=6d50199042059, content=<a href='/topic/show?id=b8eb9e78216' target=_blank style='color:#2F92EE;'>#阿尔茨海默氏#</a>, objectTitle=NSR：中国阿尔茨海默氏症有“共同”风险基因, objectType=article, longId=160415, objectId=ebf5160415a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebf5160415a8, replyNumber=0, likeNumber=76, createdTime=2019-12-09, rootId=0, userName=zhs3882, userId=b952312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebf5160415a8, moduleTitle=NSR：中国阿尔茨海默氏症有“共同”风险基因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebf5160415a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990419, encodeId=92a61990419c4, content=<a href='/topic/show?id=b8eb9e78216' target=_blank style='color:#2F92EE;'>#阿尔茨海默氏#</a>, objectTitle=NAT MED：运动如何预防阿尔茨海默氏症？, objectType=article, longId=159794, objectId=7111159e9403, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7111159e9403, replyNumber=0, likeNumber=67, createdTime=2019-05-01, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7111159e9403, moduleTitle=NAT MED：运动如何预防阿尔茨海默氏症？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7111159e9403)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990418, encodeId=2d3f1990418e8, content=<a href='/topic/show?id=b8eb9e78216' target=_blank style='color:#2F92EE;'>#阿尔茨海默氏#</a>, objectTitle=科学家证实靶向表观遗传学，可逆转阿尔茨海默氏症小鼠的记忆力衰退, objectType=article, longId=158977, objectId=4da11589e76b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4da11589e76b, replyNumber=0, likeNumber=106, createdTime=2019-11-12, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4da11589e76b, moduleTitle=科学家证实靶向表观遗传学，可逆转阿尔茨海默氏症小鼠的记忆力衰退, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4da11589e76b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990417, encodeId=93d6199041e73, content=<a href='/topic/show?id=b8eb9e78216' target=_blank style='color:#2F92EE;'>#阿尔茨海默氏#</a>, objectTitle=Nature Neurosci：一种脑细胞可能引起阿尔茨海默氏症, objectType=article, longId=156312, objectId=27df156312d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27df156312d1, replyNumber=0, likeNumber=67, createdTime=2019-03-26, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27df156312d1, moduleTitle=Nature Neurosci：一种脑细胞可能引起阿尔茨海默氏症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27df156312d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990415, encodeId=a0dd19904158d, content=<a href='/topic/show?id=b8eb9e78216' target=_blank style='color:#2F92EE;'>#阿尔茨海默氏#</a>, objectTitle=2018 国际共识：阿尔茨海默氏病患者精神和行为症状的管理, objectType=article, longId=146207, objectId=7f8314620e62, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f8314620e62, replyNumber=0, likeNumber=64, createdTime=2018-11-17, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f8314620e62, moduleTitle=2018 国际共识：阿尔茨海默氏病患者精神和行为症状的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f8314620e62)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990413, encodeId=47e0199041379, content=<a href='/topic/show?id=b8eb9e78216' target=_blank style='color:#2F92EE;'>#阿尔茨海默氏#</a>, objectTitle=Biois的阿尔茨海默氏症候选药物Eisai在PhII试验中表现出了希望, objectType=article, longId=142763, objectId=7a16142e6318, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a16142e6318, replyNumber=0, likeNumber=45, createdTime=2018-11-16, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a16142e6318, moduleTitle=Biois的阿尔茨海默氏症候选药物Eisai在PhII试验中表现出了希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a16142e6318)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990412, encodeId=22c3199041223, content=<a href='/topic/show?id=b8eb9e78216' target=_blank style='color:#2F92EE;'>#阿尔茨海默氏#</a>, objectTitle=位于生命两端：自闭症与阿尔茨海默氏症同待突破, objectType=article, longId=134080, objectId=274c134080f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=274c134080f9, replyNumber=0, likeNumber=64, createdTime=2019-01-02, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=274c134080f9, moduleTitle=位于生命两端：自闭症与阿尔茨海默氏症同待突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=274c134080f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

阿尔茨海默氏

2020-05-29

zhs3882 (审核中...)

前往app查看评论内容

#阿尔茨海默氏#

Theranexus宣布1b期研究结果，证明与多奈哌齐相比，其阿尔茨海默氏病候选药物THN201的药理学特性得到了扩展

2020-07-29

zhs3882 (审核中...)

前往app查看评论内容

#阿尔茨海默氏#

Biogen的aducanumab治疗阿尔茨海默氏病符合III期试验终点

2020-09-19

zhs3882 (审核中...)

前往app查看评论内容

#阿尔茨海默氏#

初步调查排除了中国阿尔茨海默氏症药物开发者的学术造假行为

2020-01-16

zhs3882 (审核中...)

前往app查看评论内容

#阿尔茨海默氏#

Eur Respir J：轻度至中度阿尔茨海默氏病患者阻塞性睡眠呼吸暂停和认知功能下降

2020-09-21

zhs3882 (审核中...)

前往app查看评论内容

#阿尔茨海默氏#

罗氏宣布其阿尔茨海默氏症单抗gantenerumab临床实验失败

2020-07-25

zhs3882 (审核中...)

前往app查看评论内容

#阿尔茨海默氏#

CLIN CHEM LAB MED：脑脊液液体活检确认神经元五种毒素受体（NPTXR）作为阿尔茨海默氏病进展的生物标志物？

2020-09-12

zhs3882 (审核中...)

前往app查看评论内容

#阿尔茨海默氏#

JCEM：二甲双胍与糖尿病患者阿尔茨海默氏病风险的关系

2020-07-19

zhs3882 (审核中...)

前往app查看评论内容

#阿尔茨海默氏#

默克向FDA申请，将Belsomra用于治疗阿尔茨海默氏症患者的睡眠障碍

2020-09-20

zhs3882 (审核中...)

前往app查看评论内容

#阿尔茨海默氏#

又一个阿尔茨海默氏症的候选药宣布失败：安进、诺华放弃BACE抑制剂试验

2019-11-18

zhs3882 (审核中...)

前往app查看评论内容

#阿尔茨海默氏#

INmune Bio宣布临床前数据，证明其sTNF抑制剂降低肥胖者患阿尔茨海默氏病的潜力

2020-07-07

zhs3882 (审核中...)

前往app查看评论内容

#阿尔茨海默氏#

Biogen以4500万美元收购Ionis早期阿尔茨海默氏症药物--靶向tau蛋白

2020-06-02

heli0118 (审核中...)

前往app查看评论内容

#阿尔茨海默氏#

阿尔茨海默氏症的疫苗越来越近了

2019-01-28

zhs3882 (审核中...)

前往app查看评论内容

#阿尔茨海默氏#

AmyPore治疗阿尔茨海默氏症和帕金森症的多肽药物，喜获欧盟资助

2020-04-09

zhs3882 (审核中...)

前往app查看评论内容

#阿尔茨海默氏#

NSR：中国阿尔茨海默氏症有“共同”风险基因

2019-12-09

heli0118 (审核中...)

前往app查看评论内容

#阿尔茨海默氏#

NAT MED：运动如何预防阿尔茨海默氏症？

2019-05-01

heli0118 (审核中...)

前往app查看评论内容

#阿尔茨海默氏#

科学家证实靶向表观遗传学，可逆转阿尔茨海默氏症小鼠的记忆力衰退

2019-11-12

heli0118 (审核中...)

前往app查看评论内容

#阿尔茨海默氏#

Nature Neurosci：一种脑细胞可能引起阿尔茨海默氏症

2019-03-26

heli0118 (审核中...)

前往app查看评论内容

#阿尔茨海默氏#

2018 国际共识：阿尔茨海默氏病患者精神和行为症状的管理

2018-11-17

heli0118 (审核中...)

前往app查看评论内容

#阿尔茨海默氏#

Biois的阿尔茨海默氏症候选药物Eisai在PhII试验中表现出了希望

2018-11-16

heli0118 (审核中...)

前往app查看评论内容

#阿尔茨海默氏#

位于生命两端：自闭症与阿尔茨海默氏症同待突破

2019-01-02

科室
- - 订阅+
  - 更多科室
工具
服务